Integra LifeSciences Cor...
21.91
-0.38 (-1.70%)
At close: Jan 14, 2025, 3:59 PM
undefined%
Bid 21.5
Market Cap 1.69B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -0.09
PE Ratio (ttm) -243.44
Forward PE n/a
Analyst Sell
Ask 22
Volume 238,944
Avg. Volume (20D) 760,490
Open 22.33
Previous Close 22.29
Day's Range 21.27 - 22.56
52-Week Range 16.81 - 45.42
Beta undefined

About IART

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracrani...

Sector Healthcare
IPO Date Aug 16, 1995
Employees 3,946
Stock Exchange NASDAQ
Ticker Symbol IART

Analyst Forecast

According to 7 analyst ratings, the average rating for IART stock is "Sell." The 12-month stock price forecast is $22, which is an increase of 0.41% from the latest price.

Buy 14.29%
Hold 42.86%
Sell 42.86%
Stock Forecasts

Next Earnings Release

Integra LifeSciences Corporation is scheduled to release its earnings on Feb 26, 2025, before market opens.
Analysts project revenue of $445.15M, reflecting a 12.12% YoY growth and earnings per share of 0.85, making a -4.49% decrease YoY.
2 months ago · Source
+25.1%
Integra LifeSciences shares are trading higher aft... Unlock content with Pro Subscription
5 months ago · Source
-1.53%
Integra Lifesciences shares are trading lower after Citigroup and BTIG both downgraded the stock from Neutral to Sell. The company recently lowered its FY24 guidance.